Sanofi SA is weighing an acquisition of US drugmaker Insmed Inc., people familiar with the matter said, as the French pharmaceuticals company hunts for its next blockbuster treatment under a new CEO.
Sanofi SA is weighing an acquisition of US drugmaker Insmed Inc., people familiar with the matter said, as the French pharmaceuticals company hunts for its next blockbuster treatment under a new CEO.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)